Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease

Published:2022-02-01 Issue:3 Volume:205 Page:313-323
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ghosh Auyon J.¹²^ORCID,Hobbs Brian D.¹²³^ORCID,Moll Matthew¹²,Saferali Aabida¹,Boueiz Adel¹²³,Yun Jeong H.¹²³^ORCID,Sciurba Frank⁴,Barwick Lucas⁵,Limper Andrew H.⁶,Flaherty Kevin⁷,Criner Gerard⁸,Brown Kevin K.⁹,Wise Robert¹⁰^ORCID,Martinez Fernando J.¹¹,Lomas David¹²,Castaldi Peter J.¹³,Carey Vincent J.¹³,DeMeo Dawn L.¹²³,Cho Michael H.¹²³^ORCID,Silverman Edwin K.¹²³,Hersh Craig P.¹²³^ORCID,Crapo James D.,Silverman Edwin K.,Make Barry J.,Regan Elizabeth A.,Beaty Terri H.,Castaldi Peter J.,Cho Michael H.,DeMeo Dawn L.,El-Boueiz Adel,Foreman Marilyn G.,Ghosh Auyon J.,Hayden Lystra P.,Hersh Craig P.,Hetmanski Jacqueline,Hobbs Brian D.,Hokanson John E.,Kim Wonji,Laird Nan,Lange Christoph,Lutz Sharon M.,McDonald Merry-Lynn,Prokopenko Dmitry,Moll Matthew,Morrow Jarrett,Qiao Dandi,Saferali Aabida,Sakornsakolpat Phuwanat,Wan Emily S.,Yun Jeong H.,Centeno Juan Pablo,Charbonnier Jean-Paul,Coxson Harvey O.,Galban Craig J.,Han MeiLan K.,Hoffman Eric A.,Humphries Stephen,Jacobson Francine L.,Judy Philip F.,Kazerooni Ella A.,Kluiber Alex,Lynch David A.,Nardelli Pietro,Newell John D.,Notary Aleena,Oh Andrea,Ross James C.,Estepar Raul San Jose,Schroeder Joyce,Sieren Jered,Stoel Berend C.,Tschirren Juerg,Van Beek Edwin,van Ginneken Bram,van Rikxoort Eva,Sanchez-Ferrero Gonzalo Vegas,Veitel Lucas,Washko George R.,Wilson Carla G.,Jensen Robert,Everett Douglas,Crooks Jim,Pratte Katherine,Strand Matt,Austin Erin,Kinney Gregory,Young Kendra A.,Bhatt Surya P.,Bon Jessica,Diaz Alejandro A.,Make Barry,Murray Susan,Regan Elizabeth,Soler Xavier,Bowler Russell P.,Kechris Katerina,Banaei-Kashani Farnoush,Curtis Jeffrey L.,Pernicano Perry G.,Hanania Nicola,Atik Mustafa,Boriek Aladin,Guntupalli Kalpatha,Guy Elizabeth,Parulekar Amit,Hersh Craig,Washko George,Barr R. Graham,Austin John,D’Souza Belinda,Thomashow Byron,MacIntyre Neil,McAdams H. Page,Washington Lacey,McEvoy Charlene,Tashjian Joseph,Wise Robert,Brown Robert,Hansel Nadia N.,Horton Karen,Lambert Allison,Putcha Nirupama,Casaburi Richard,Adami Alessandra,Budoff Matthew,Fischer Hans,Porszasz Janos,Rossiter Harry,Stringer William,Sharafkhaneh Amir,Lan Charlie,Wendt Christine,Bell Brian,Kunisaki Ken M.,Flenaugh Eric L.,Gebrekristos Hirut,Ponce Mario,Terpenning Silanath,Westney Gloria,Rosiello Richard,Pace David,Criner Gerard,Ciccolella David,Cordova Francis,Dass Chandra,D’Alonzo Gilbert,Desai Parag,Jacobs Michael,Kelsen Steven,Kim Victor,Mamary A. James,Marchetti Nathaniel,Satti Aditi,Shenoy Kartik,Steiner Robert M.,Swift Alex,Swift Irene,Vega-Sanchez Maria Elena,Dransfield Mark,Bailey William,Iyer Anand,Nath Hrudaya,Wells J. Michael,Conrad Douglas,Yen Andrew,Comellas Alejandro P.,Hoth Karin F.,Newell John,Thompson Brad,Kazerooni Ella,Labaki Wassim,Galban Craig,Vummidi Dharshan,Billings Joanne,Begnaud Abbie,Allen Tadashi,Sciurba Frank,Chandra Divay,Weissfeld Joel,Anzueto Antonio,Adams Sandra,Maselli-Caceres Diego,Ruiz Mario E.,Singh Harjinder

Affiliation:

1. Channing Division of Network Medicine and

2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts;

3. Harvard Medical School, Harvard University, Boston, Massachusetts;

4. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania;

5. The Emmes Company, Rockville, Maryland;

6. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota;

7. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan;

8. Department of Thoracic Medicine and Surgery, Temple University, Philadelphia, Pennsylvania;

9. Department of Medicine, National Jewish Health, Denver, Colorado;

10. Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland;

11. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York; and

12. University College London Respiratory Division of Medicine, University College London, London, United Kingdom

Funder

NIH

Alpha-1 Foundation

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference40 articles.

1. Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes

2. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups

3. α; 1 -Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts

4. Serum levels and genotype distribution of α1-antitrypsin in the general population

5. Protein Misfolding and Obstructive Lung Disease

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allelic frequency of pathogenic α1-antitrypsin variants in the Japanese population: Results from a survey of open Japanese genetic variation databases;Respiratory Investigation;2024-09

2. Lung Single-Cell Transcriptomics in Alpha-1 Antitrypsin Deficiency;American Journal of Respiratory Cell and Molecular Biology;2024-08

3. Genetic background of pulmonary (vascular) diseases – how much is written in the codes?;Current Opinion in Pulmonary Medicine;2024-06-24

4. Alpha-1 Antitrypsin Phenotyping: An Unmet Educational Need of Healthcare Providers;Journal of Clinical Medicine Research;2024-03

5. Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?;Journal of Clinical Medicine;2024-02-14